keyword
https://read.qxmd.com/read/38454079/comparative-effectiveness-research-trial-for-antidepressant-incomplete-and-non-responders-with-treatment-resistant-depression-ascertain-trd-a-randomized-clinical-trial
#21
JOURNAL ARTICLE
George I Papakostas, Madhukar H Trivedi, Richard C Shelton, Dan V Iosifescu, Michael E Thase, Manish K Jha, Sanjay J Mathew, Charles DeBattista, Mehmet E Dokucu, Olga Brawman-Mintzer, Glenn W Currier, William Vaughn McCall, Mandana Modirrousta, Matthew Macaluso, Alexander Bystritsky, Fidel Vila Rodriguez, Erik B Nelson, Albert S Yeung, Anna Feeney, Leslie C MacGregor, Thomas Carmody, Maurizio Fava
Further research is needed to help improve both the standard of care and the outcome for patients with treatment-resistant depression. A particularly critical evidence gap exists with respect to whether pharmacological or non-pharmacological augmentation is superior to antidepressant switch, or vice-versa. The objective of this study was to compare the effectiveness of augmentation with aripiprazole or repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine XR (or duloxetine for those not eligible to receive venlafaxine) for treatment-resistant depression...
March 7, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38420276/factors-associated-with-psychotic-and-depressive-symptoms-in-methamphetamine-users
#22
JOURNAL ARTICLE
Sercan Karabulut
Objective: Methamphetamine use has been recognized as a prominent public health issue, which is associated with psychotic and depressive symptoms. This study aimed to assess factors that show a significant relation with psychotic and depressive symptoms in adults who use methamphetamine. Method : We assessed 95 patients who had used methamphetamine within the last month and were admitted to the outpatient treatment clinic. Evaluation of all patients was carried out through face-to-face interviews, and their symptoms were evaluated using different scales...
January 2024: Iranian Journal of Psychiatry
https://read.qxmd.com/read/38381901/prospective-comparative-pilot-study-of-maintenance-treatment-in-comorbid-bipolar-disorders-with-post-traumatic-stress-disorder
#23
JOURNAL ARTICLE
Hernán F Guillen-Burgos, Juan F Gálvez-Flórez, Sergio Moreno-Lopez, Angela T H Kwan, Roger S McIntyre
There is limited real-world evidence that evaluates the impact of monotherapy vs. combination therapy as a maintenance treatment in comorbid post-traumatic stress disorder (PTSD) in bipolar disorder (BD). Our aim was to compare lithium vs. lithium plus quetiapine in maintenance treatment in a sample of comorbid BD with PTSD. An exploratory, comparative pilot study over a 28-week period in 34 comorbid BD with PTSD patients was performed to compare monotherapy (n = 18) vs. combination therapy (n = 16) during maintenance treatment...
February 22, 2024: International Clinical Psychopharmacology
https://read.qxmd.com/read/38367320/adjunctive-cariprazine-as-a-novel-effective-strategy-for-treating-major-depressive-disorder-a-systematic-review-and-meta-analysis
#24
REVIEW
Minjia Xie, Youjia Qiu, Menghan Wang, Xingzhou Wei, Yuchen Tao, Aojie Duan, Jing Shang, Wei Gao, Zhong Wang
BACKGROUND: Cariprazine has been approved by the Food and Drug Administration for treating bipolar depression and as an adjunctive treatment for Major Depressive Disorder (MDD). However, it remains unclear about its pharmacological efficacy in treating MDD. Therefore, a meta-analysis was conducted to investigate the adjunctive use of cariprazine in MDD. METHODS: Electronic databases were searched for eligible studies evaluating the efficacy and safety of cariprazine in patients with MDD up to November 15, 2023...
February 8, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38340111/combination-of-acute-and-maintenance-esketamine-treatment-with-adjunctive-long-term-vagus-nerve-stimulation-in-difficult-to-treat-depression
#25
JOURNAL ARTICLE
Erhan Kavakbasi, Bernhard T Baune
INTRODUCTION: The antidepressant effect of N-methyl-D-aspartate antagonists is often short lasting, raising the question of the best maintenance strategy, which has remained unanswered. Vagus nerve stimulation (VNS) as a treatment option for refractory and chronic major depression was shown to reduce the need for maintenance treatment sessions in patients receiving electroconvulsive therapy. To our knowledge, there are no published data on the combination of VNS and esketamine in the literature...
February 10, 2024: Neuromodulation: Journal of the International Neuromodulation Society
https://read.qxmd.com/read/38331652/predictors-of-the-placebo-response-in-a-nutraceutical-randomized-controlled-trial-for-depression
#26
JOURNAL ARTICLE
Rosemary Arnold, Jenifer Murphy-Smith, Chee H Ng, David Mischoulon, Gerard J Byrne, Chad A Bousman, Con Stough, Michael Berk, Jerome Sarris
OBJECTIVE: The placebo response in depression studies is the change in symptoms amongst those who receive an inactive treatment. Many well-designed randomized controlled trials (RCTs) of depression have a high proportion of placebo responders, with little understanding as to why. The present study assesses characteristics associated with the placebo response in a nutraceutical trial with a large proportion of placebo responders. METHODS: This is a secondary analysis of a nutraceutical depression RCT which identified no overall treatment benefit relative to placebo (n = 69 in placebo group)...
January 24, 2024: Journal of Integrative Medicine
https://read.qxmd.com/read/38328763/the-association-between-neuroendocrine-glucose-metabolism-and-clinical-outcomes-and-disease-course-in-different-clinical-states-of-bipolar-disorders
#27
JOURNAL ARTICLE
Xu Zhang, Yaling Zhou, Yuexin Chen, Shengnan Zhao, Bo Zhou, Xueli Sun
OBJECTIVE: The treatment of bipolar disorder (BD) remains challenging. The study evaluated the impact of the hypothalamic-pituitary-adrenal (HPA) axis/hypothalamic-pituitary-thyroid (HPT) axis and glucose metabolism on the clinical outcomes in patients with bipolar depression (BD-D) and manic bipolar (BD-M) disorders. METHODS: The research design involved a longitudinal prospective study. A total of 500 BD patients aged between 18 and 65 years treated in 15 hospitals located in Western China were enrolled in the study...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38327216/incidence-and-outcomes-of-kidney-replacement-therapy-for-end-stage-kidney-disease-due-to-primary-glomerular-disease-in-europe-findings-from-the-era-registry
#28
JOURNAL ARTICLE
Samar Abd ElHafeez, Anneke Kramer, Mustafa Arici, Miha Arnol, Anders Åsberg, Samira Bell, Julie Belliere, Carmen Díaz Corte, Gema Fernández Fresnedo, Marc Hemmelder, Line Heylen, Kristine Hommel, Julia Kerschbaum, Radomir Naumović, Dorothea Nitsch, Rafael Santamaria, Patrik Finne, Runolfur Palsson, Maria Pippias, Halima Resic, Mai Rosenberg, Carmen Santiuste de Pablos, Mårten Segelmark, Søren Schwartz Sørensen, Maria Jose Soler, Enrico Vidal, Kitty J Jager, Alberto Ortiz, Vianda S Stel
BACKGROUND AND HYPOTHESIS: Primary glomerular disease (PGD) is a major cause of end-stage kidney disease (ESKD) leading to kidney replacement therapy (KRT). We aimed to describe incidence (trends) in individuals starting KRT for ESKD due to PGD and to examine their survival and causes of death. METHODS: We used data from the European Renal Association (ERA) Registry on 69 854 patients who started KRT for ESKD due to PGD between 2000 and 2019. ERA primary renal disease codes were used to define six PGD subgroups...
February 7, 2024: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/38311973/impact-of-biological-rhythms-on-perception-of-illness-and-cognitive-flexibility-in-bipolar-patients-in-remission
#29
JOURNAL ARTICLE
Hanife Kocakaya, Sinan Yetkin
Our study aims to examine the possible mediating effects of biological rhythms on the relationship between illness perception, cognitive flexibility, and functionality in bipolar patients in remission. A total of 150 patients with bipolar disorder (BD) were enrolled. The sociodemographic data form, Biological Rhythm Interview of Assessment in Neuropsychiatry (BRIAN), Brief Illness Perception Questionnaire (BIPQ), Cognitive Flexibility Scale (CFS), Young Mania Rating Scale, Montgomery and Asberg Depression Scale, Beck Anxiety Inventory, and Short Functionality Assessment Scale were applied to the patients in the study...
February 4, 2024: Chronobiology International
https://read.qxmd.com/read/38298006/is-visual-prediction-impaired-in-adolescents-with-autism-spectrum-disorder-event-related-potentials-in-a-cued-visual-go-nogo-task
#30
JOURNAL ARTICLE
Linda A Häger, Anne L Høyland, Juri D Kropotov, Jakob Åsberg Johnels, Benhard Weidle, Stig Hollup, Christopher Gillberg, Eva Billstedt, Geir Ogrim
Aim: Deviant visual processing has been observed in autism spectrum disorder (ASD), manifesting as decreased P1 and P2 components of visual event-related potentials (ERPs). Alterations have been attributed to a failure of Bayesian inference, characterized by hypo-activation of top-down predictive abilities. To test this hypothesis, we measured the visual negativity (vN) as an ERP index of visual preparation hypothesized to mirror predictive brain activity. Method: ERPs in a cued visual GO/NOGO task in 63 adolescents with ASD (IQ > 70, attention-deficit hyperactivity disorder excluded) were compared with ERPs in a sex- and age-matched group of 60 typically developing (TD) controls...
January 31, 2024: Clinical EEG and Neuroscience: Official Journal of the EEG and Clinical Neuroscience Society (ENCS)
https://read.qxmd.com/read/38286230/ketamine-for-major-depressive-disorder-during-an-inpatient-psychiatric-admission-effectiveness-adverse-events-and-lessons-learned
#31
JOURNAL ARTICLE
Benjamin D Brody, Nana Park, Alexander Christian, Charles W Shaffer, Roy Smetana, Nabil Kotbi, Mark J Russ, Dora Kanellopoulos
OBJECTIVE: Most studies examining the efficacy of ketamine for Major Depressive Disorder (MDD) have been conducted in outpatient or mixed inpatient/outpatient settings. Less is known about effectiveness and tolerability of ketamine for psychiatrically hospitalized patients. Efficacy and tolerability data from a naturalistic sample of acute inpatients may help inform institutions considering ketamine therapy for inpatient services. METHODS: We performed a retrospective chart review of inpatients with non-psychotic MDD treated during the initial 3 years of a ketamine infusion program...
January 28, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38280948/long-term-medication-for-adhd-lma-trial-2-year-prospective-observational-study-in-children-and-adolescents-core-symptoms-daily-functioning-and-comorbidity-outcomes
#32
JOURNAL ARTICLE
M Johnson, J Åsberg Johnels, S Östlund, K Jakobsson, J Högstedt, P Javid Larsson, C Gillberg, E Billstedt
More knowledge is needed about long-term ADHD medication and symptom, daily functioning, comorbidity, and tolerability outcomes. This "Long-term Medication for ADHD (LMA) trial" was a prospective observational 2-year trial in children and adolescents aged 6-18 years (extension of 1-year trial). Participants met criteria for DSM-5 ADHD (inattentive or combined), with complex comorbidities; autism spectrum disorder (31%), autistic traits (24%), oppositional symptoms (59%), anxiety (32%), dyslexia/language disorder (16%), borderline intellectual functioning (17%)...
January 27, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38247422/treating-treatment-resistant-depression-with-esketamine-nasal-spray-when-all-therapeutic-options-have-been-exhausted-clinical-experience-from-a-spanish-cohort-of-expanded-use
#33
JOURNAL ARTICLE
Júlia Vendrell-Serres, Óscar Soto-Angona, Amanda Rodríguez-Urrutia, Benedetta Inzoli, Antonia López González, Josep Antoni Ramos-Quiroga
OBJECTIVE: : Treatment Resistant Depression (TRD) is commonly defined as the lack of response to two or more anti-depressants with different mechanisms of action. Up to 30% of patients diagnosed with major depressive disorder might be considered to present TRD. The objective of this study was to assess the effectiveness and tolerability of esketamine in patients diagnosed with TRD, who were referred to our program after exhausting all available treatments. A secondary objective consisted in researching the relationship between response and previous use of electroconvulsive therapy...
February 29, 2024: Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology
https://read.qxmd.com/read/38241898/characterization-of-antibody-surface-properties-and-selection-of-a-diverse-subset-for-development-of-a-generic-size-exclusion-chromatography-method
#34
JOURNAL ARTICLE
Marika E Reinau, Dennis Åsberg
Aggregates are an important quality attribute for biotherapeutics because they can affect the safety and efficacy of the drug and they are therefore routinely monitored, mainly with size-exclusion chromatography (SEC). However, there is often a need to tailor a SEC method to a specific molecule. This study describes the development of a generic SEC method tested on 138 antibodies with the variable domains taken from clinical stage antibodies. We report on the discovery of a subset of 12 antibodies that represents the full range of physiochemical properties found in the 138 antibodies...
January 13, 2024: Journal of Chromatography. A
https://read.qxmd.com/read/38231578/dextromethorphan-bupropion-a-novel-treatment-for-patients-with-major-depressive-disorder
#35
JOURNAL ARTICLE
Kristine C Willett, LeDea R Bond, Amanda M Morrill, Dima Lorena, Ifteni Petru
BACKGROUND: Major depressive disorder (MDD) affects millions of people and is the leading cause of disability worldwide. Patients report decreased quality of life and ability to perform activities of daily living. It is estimated that the current standard of care, which includes pharmacologic therapy with a selective serotonin reuptake inhibitor, is effective in 40%-60%. Additional treatment options are warranted. The combination of dextromethorphan (DEX) and bupropion (BUP) (Auveulty) was approved for treatment in 2022...
January 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38224226/significance-of-inflammatory-markers-in-primary-fibromyalgia-syndrome-and-their-relation-in-assessing-the-disease-severity
#36
JOURNAL ARTICLE
Esraa A El-Sawy, Mervat M Abdul Hakim, Abeer El-Zohiery, Sherihan M Salama
Fibromyalgia syndrome (FMS) is a musculoskeletal disorder characterized by diffuse chronic musculoskeletal pain associated with various other symptoms. Although the etiology and pathogenesis of FMS are still unclear, it was reported to have a possible inflammatory basis. No laboratory marker is currently available to diagnose the disease. This study aimed to search for biomarkers useful in diagnosis of FMS. We assessed blood erythrocyte sedimentation rate (ESR), neutrophil lymphocyte ratio (NLR), the mean platelet volume (MPV) and platelet distribution width (PDW), and serum levels of C-reactive protein (CRP), as inflammatory markers in primary FMS patients and their relationship with disease severity and depression scores...
January 2024: Egyptian Journal of Immunology
https://read.qxmd.com/read/38218932/active-versus-sham-dlpfc-nac-rtms-for-depressed-adolescents-with-anhedonia-using-resting-state-functional-magnetic-resonance-imaging-fmri-a-study-protocol-for-a-randomized-placebo-controlled-trial
#37
JOURNAL ARTICLE
Runxin Lv, Min Cai, Nailong Tang, Yifan Shi, Yuyu Zhang, Nian Liu, Tianle Han, Yaochi Zhang, Huaning Wang
BACKGROUND: Anhedonia, which is defined as the inability to feel pleasure, is considered a core symptom of major depressive disorder (MDD). It can lead to several adverse outcomes in adolescents, including heightened disease severity, resistance to antidepressants, recurrence of MDD, and even suicide. Specifically, patients who suffer from anhedonia may exhibit a limited response to selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy (CBT). Previous researches have revealed a link between anhedonia and abnormalities within the reward circuitry, making the nucleus accumbens (NAc) a potential target for treatment...
January 13, 2024: Trials
https://read.qxmd.com/read/38190276/omega-3-supplementation-improves-depressive-symptoms-cognitive-function-and-niacin-skin-flushing-response-in-adolescent-depression-a-randomized-controlled-clinical-trial
#38
RANDOMIZED CONTROLLED TRIAL
Shuhui Li, Rulan Li, Xiaowen Hu, Yue Zhang, Dandan Wang, Yan Gao, Jinfeng Wang, Qian Wang, Chuanfu Song, Shucai Huang, En Zhang, Juan Zhang, Zhong Xia, Chunling Wan
BACKGROUND: Depressive disorder in adolescents is a major health problem with inadequate treatment. Omega-3 (ω3) polyunsaturated fatty acids are a promising adjuvant therapy in adult depression. The primary objective of this study was to investigate the efficacy of adjuvant ω3 treatment on depressive symptoms in adolescent depression. Secondarily, we explored the effects of ω3 on cognitive function and memory and niacin skin flushing response (NSFR), as their robust associations with adolescent depression...
January 15, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38179107/ketamine-for-postoperative-avoidance-of-depressive-symptoms-the-k-pass-feasibility-randomised-trial
#39
JOURNAL ARTICLE
Bradley A Fritz, Bethany R Tellor Pennington, Catherine Dalton, Christine Horan, Ben J A Palanca, Julie A Schweiger, Logan Griffin, Wilberforce Tumwesige, Jon T Willie, Nuri B Farber
BACKGROUND: Surgical patients with previous depression frequently experience postoperative depressive symptoms. This study's objective was to determine the feasibility of a placebo-controlled trial testing the impact of a sustained ketamine infusion on postoperative depressive symptoms. METHODS: This single-centre, triple-blind, placebo-controlled randomised clinical trial included adult patients with depression scheduled for inpatient surgery. After surgery, patients were randomly allocated to receive ketamine (0...
March 2024: BJA Open
https://read.qxmd.com/read/38157709/optimal-risk-and-diagnosis-assessment-strategies-in-perinatal-depression-a-machine-learning-approach-from-the-life-on-study-cohort
#40
JOURNAL ARTICLE
Armando D'Agostino, Corrado Garbazza, Daniele Malpetti, Laura Azzimonti, Francesca Mangili, Hans-Christian Stein, Renata Del Giudice, Alessandro Cicolin, Fabio Cirignotta, Mauro Manconi
This study aimed to assess the concordance of various psychometric scales in detecting Perinatal Depression (PND) risk and diagnosis. A cohort of 432 women was assessed at 10-15th and 23-25th gestational weeks, 33-40 days and 180-195 days after delivery using the Edinburgh Postnatal Depression Scale (EPDS), Visual Analogue Scale (VAS), Hamilton Depression Rating Scale (HDRS), Montgomery-Åsberg Depression Rating Scale (MADRS), and Mini International Neuropsychiatric Interview (MINI). Spearman's rank correlation coefficient was used to assess agreement across instruments, and multivariable classification models were developed to predict the values of a binary scale using the other scales...
December 24, 2023: Psychiatry Research
keyword
keyword
111401
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.